Prenatal diagnosis of ATR-X syndrome in a fetus with a new G>T splicing mutation in the XNP/ATR-X gene

被引:10
作者
Fichera, M
Silengo, M
Spalletta, A
Lo Giudice, M
Romano, C
Ragusa, A
机构
[1] IRCCS, Oasi Maria SS, Lab Patol Genet, I-94018 Troina, EN, Italy
[2] Univ Turin, Osped Infantile Regina Margherita, Dipartimento Clin Pediat, Turin, Italy
[3] IRCCS, Oasi Maria SS, Dipartimento Pediat, Turin, Italy
关键词
ATR-X syndrome; XNP/ATR-X gene; disease-associated haplotype; prenatal diagnosis;
D O I
10.1002/pd.142
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular cause of the alpha -thalassemia/mental retardation syndrome (ATR-X) resides in mutations affecting the XNP/ATR-X gene. Recently molecular defects in the gene have been found in singular cases of a discrete number of X-linked mental retardation (XLMR). ATR-X-affected males are characterised by severe mental retardation, distinct facial dysmorphisms and genital abnormalities, besides a wide spectrum of pathological features and an extremely limited biological fitness. Given that molecular investigation of XNP/ATR-X mutations is made onerous by the length of the gene transcript, we carried out a prenatal diagnosis in a fetus at risk for ATR-X syndrome by initially determining the XNP/ATR-X gene haplotype before considering gene sequencing. Disease-associated haplotype analysis was performed selecting five genic (CA)(n) repeats that showed high heterozygosity (Het > 0.7) in the general population. The fetus segregated an identical allelic pattern to that of the affected child of the family under investigation who shows features suggestive of the ATR-X syndrome. Subsequent mutational analysis of the gene revealed a novel IVS3+1G >T splicing mutation confirming the diagnosis. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:747 / 751
页数:5
相关论文
共 19 条
[1]  
Abidi F, 1999, AM J MED GENET, V85, P249, DOI 10.1002/(SICI)1096-8628(19990730)85:3<249::AID-AJMG12>3.0.CO
[2]  
2-U
[3]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[4]   Germline and gonosomal mosaicism in the ATR-X syndrome [J].
Bachoo, S ;
Gibbons, RJ .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (08) :933-936
[5]  
BORGIONE E, 2001, J MED GENET, V38, P1
[6]   ISOLATION AND CHARACTERIZATION OF A HUMAN VARIABLE COPY NUMBER TANDEM REPEAT AT XCEN-P11.22 [J].
FRASER, NJ ;
BOYD, Y ;
CRAIG, I .
GENOMICS, 1989, 5 (01) :144-148
[7]  
GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136
[8]   CLINICAL AND HEMATOLOGIC ASPECTS OF THE X-LINKED ALPHA-THALASSEMIA MENTAL-RETARDATION SYNDROME (ATR-X) [J].
GIBBONS, RJ ;
BRUETON, L ;
BUCKLE, VJ ;
BURN, J ;
CLAYTONSMITH, J ;
DAVISON, BCC ;
GARDNER, RJM ;
HOMFRAY, T ;
KEARNEY, L ;
KINGSTON, HM ;
NEWBURYECOB, R ;
PORTEOUS, MEP ;
WILKIE, AOM ;
HIGGS, DR .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 55 (03) :288-299
[9]   MUTATIONS IN A PUTATIVE GLOBAL TRANSCRIPTIONAL REGULATOR CAUSE X-LINKED MENTAL-RETARDATION WITH ALPHA-THALASSEMIA (ATR-X SYNDROME) [J].
GIBBONS, RJ ;
PICKETTS, DJ ;
VILLARD, L ;
HIGGS, DR .
CELL, 1995, 80 (06) :837-845
[10]   Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain [J].
Gibbons, RJ ;
Bachoo, S ;
Picketts, DJ ;
Aftimos, S ;
Asenbauer, B ;
Bergoffen, J ;
Berry, SA ;
Dahl, N ;
Fryer, A ;
Keppler, K ;
Kurosawa, K ;
Levin, ML ;
Masuno, M ;
Neri, G ;
Pierpont, ME ;
Slaney, SF ;
Higgs, DR .
NATURE GENETICS, 1997, 17 (02) :146-148